共享决策工具用于无扁桃体肥大的阻塞性睡眠呼吸暂停:一项随机对照试验
这项前瞻性单盲随机对照试验纳入50个无扁桃体肥大的阻塞性睡眠呼吸暂停患儿家庭,评估共享决策工具对决策冲突的影响。
要点
- 共享决策工具可降低无扁桃体肥大OSA患儿家庭的决策冲突。
- 访后决策冲突量表得分工具组6.1,对照组13.3,差异有统计学意义。
核心结论
- 使用共享决策工具进行治疗选项咨询的家庭,其决策冲突显著低于未使用工具的家庭。
研究设计与样本
- 前瞻性、单盲、随机对照试验,纳入连续就诊于多学科上气道中心的符合纳入标准患者,共评估50个家庭(研究组24例,对照组26例)。
主要发现
- 访前对照组63%、研究组58%对选项不确定;访后分别改善至4.1%和0%。
- 平均年龄8.8±6.6岁,44%为女性,86%为白人,平均阻塞性呼吸暂停低通气指数12.7±15.6次/小时。
临床怎么用
- 临床医生应考虑将共享决策工具整合到无扁桃体肥大OSA患儿的临床实践中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Shared decision-making is a process whereby patients and clinicians jointly establish a treatment plan integrating clinical evidence and patient values and preferences. Although this approach has been successfully employed in numerous medical disciplines, often using shared decision-making tools, otolaryngologic research assessing its use is scant. Our primary objective was therefore to determine if the tools we developed reduced decisional conflict for children with obstructive sleep apnea without tonsillar hypertrophy. STUDY DESIGN: Prospective, single-blind, randomized controlled trial. METHODS: We enrolled consecutive patients meeting inclusion criteria who were referred to our multidisciplinary upper airway center. Study patients used a shared decision-making tool whereas controls did not. Measures of decisional conflict (SURE [Sure of myself, Understanding information, Risk benefit ratio, Encouragement], CollaboRATE, and the Decisional Conflict Scale [DCS]) were obtained pre- and postvisit. RESULTS: We assessed 50 families (study group = 24, controls = 26). The mean age was 8.8 ± 6.6 years, 44% were female, 86% were white, and the mean obstructive apnea-hypopnea index was 12.7 ± 15.6 events/hour. The previsit mean DCS score was similar for controls (42.7) and study patients (40.8) (P = .38). The postvisit mean DCS score for controls was 13.3 and for study patients 6.1 (P = .034). Improvement in this score was greater in the study group (P = .03). At previsit evaluation, 63% of controls and 58% of study patients were unsure about their options. Postvisit, this improved to 4.1% and 0%, respectively. CONCLUSIONS: Families counseled regarding treatment options using shared decision-making tools had significantly less decisional conflict than those who did not use these tools. These positive outcomes suggest that clinicians should consider integrating this approach into clinical practice. LEVEL OF EVIDENCE: 1b. Laryngoscope, 128:1007-1015, 2018.
引用
- Bergeron M, Duggins AL, Cohen AP, et al. A shared decision-making tool for obstructive sleep apnea without tonsillar hypertrophy: A randomized controlled trial. Laryngoscope. 2017. PMID: 29114896. doi:10.1002/lary.26967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。